ASA404 or Placebo in Combination With Paclitaxel and Carboplatin as First-Line Treatment for Stage IIIb/IV Non-Small Cell Lung Cancer
Clinical trial NCT00662597 · TERMINATED
Trial details
- NCT number
- NCT00662597
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-04-01
- Primary completion
- 2010-05-01
- Enrollment
- 1285
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.